A Study of the Effectiveness and Safety of High Dose, Short-Course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.
This study has been completed.
Study NCT00042718
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: August 5, 2002
Last Updated: May 21, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
